Hakan Kardes Sells 14,500 Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Hakan Kardes sold 14,500 shares of the firm’s stock in a transaction on Friday, January 24th. The shares were sold at an average price of $14.98, for a total value of $217,210.00. Following the sale, the insider now directly owns 295,444 shares in the company, valued at approximately $4,425,751.12. This trade represents a 4.68 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Hakan Kardes also recently made the following trade(s):

• On Tuesday, January 21st, Hakan Kardes sold 10,500 shares of Alignment Healthcare stock. The shares were sold at an average price of $14.99, for a total value of $157,395.00.
• On Wednesday, November 27th, Hakan Kardes sold 35,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $12.80, for a total value of $448,000.00.
• On Monday, November 4th, Hakan Kardes sold 20,500 shares of Alignment Healthcare stock. The stock was sold at an average price of $13.06, for a total value of $267,730.00.
• On Friday, November 1st, Hakan Kardes sold 4,500 shares of Alignment Healthcare stock. The stock was sold at an average price of $12.98, for a total value of $58,410.00.

Alignment Healthcare Price Performance

Alignment Healthcare stock opened at $14.97 on Friday. Alignment Healthcare, Inc. has a 12 month low of $4.46 and a 12 month high of $15.05. The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 1.82. The business’s 50 day simple moving average is $12.13 and its 200 day simple moving average is $11.02. The company has a market cap of $2.87 billion, a price-to-earnings ratio of -19.44 and a beta of 1.45.

Alignment Healthcare (NASDAQ:ALHC) last posted its quarterly earnings data on Tuesday, October 29th. The company reported ($0.14) EPS for the quarter, meeting the consensus estimate of ($0.14). Alignment Healthcare had a negative return on equity of 108.69% and a negative net margin of 5.84%. The business had revenue of $692.43 million for the quarter, compared to the consensus estimate of $662.11 million. During the same quarter in the prior year, the business earned ($0.19) earnings per share. Alignment Healthcare’s revenue for the quarter was up 51.6% on a year-over-year basis. Sell-side analysts forecast that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Hedge Funds Weigh In On Alignment Healthcare

Several institutional investors have recently bought and sold shares of the company. R Squared Ltd bought a new stake in Alignment Healthcare during the 4th quarter valued at $55,000. nVerses Capital LLC bought a new stake in Alignment Healthcare during the 3rd quarter valued at $95,000. Ballentine Partners LLC bought a new stake in Alignment Healthcare during the 4th quarter valued at $121,000. Connor Clark & Lunn Investment Management Ltd. bought a new stake in Alignment Healthcare during the 3rd quarter valued at $131,000. Finally, Creative Planning raised its holdings in Alignment Healthcare by 20.0% during the 3rd quarter. Creative Planning now owns 12,442 shares of the company’s stock valued at $147,000 after acquiring an additional 2,072 shares during the period. Hedge funds and other institutional investors own 86.19% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on ALHC shares. Stephens reissued an “overweight” rating and issued a $17.00 price objective on shares of Alignment Healthcare in a research report on Thursday, January 2nd. KeyCorp initiated coverage on Alignment Healthcare in a research note on Friday, October 11th. They set a “sector weight” rating for the company. UBS Group lifted their price target on Alignment Healthcare from $9.00 to $12.00 and gave the company a “neutral” rating in a research note on Wednesday, October 30th. Barclays lifted their price target on Alignment Healthcare from $7.00 to $8.00 and gave the company an “underweight” rating in a research note on Wednesday, October 30th. Finally, Stifel Nicolaus lifted their price target on Alignment Healthcare from $14.00 to $16.00 and gave the company a “buy” rating in a research note on Tuesday, January 14th. One research analyst has rated the stock with a sell rating, two have given a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $11.88.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.